HomeXVIPF • OTCMKTS
add
Xvivo Perfusion AB
Previous close
$16.98
Year range
$16.98 - $45.90
Market cap
5.97B SEK
Avg Volume
13.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 189.14M | -4.71% |
Operating expense | 124.48M | -2.34% |
Net income | 4.34M | -94.94% |
Net profit margin | 2.29 | -94.70% |
Earnings per share | 0.13 | -95.29% |
EBITDA | 40.91M | 35.01% |
Effective tax rate | 70.61% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 279.94M | -37.79% |
Total assets | 2.38B | 4.35% |
Total liabilities | 283.45M | 45.35% |
Total equity | 2.09B | — |
Shares outstanding | 31.50M | — |
Price to book | 0.26 | — |
Return on assets | 1.88% | — |
Return on capital | 2.03% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 4.34M | -94.94% |
Cash from operations | 20.59M | -9.99% |
Cash from investing | -60.62M | -46.14% |
Cash from financing | -3.76M | -43.70% |
Net change in cash | -43.05M | -39.85% |
Free cash flow | -48.59M | 50.26% |
About
Founded
1998
Website
Employees
200
